Amy L. Friedman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amy L. Friedman has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Marc I. Lorber
Yale University School of Medicine
2 shared publicationsAlan S. Kliger
Yale University School of Medicine
1 shared publicationDennis Cooper
1 shared publicationE Azhderian
1 shared publicationG.D. Lee
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA
1 shared publicationGiacomo P. Basadonna
Yale University School of Medicine
1 shared publication
Latest Publications
- Open Access
- 1 March 2007
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 142 (3) , 278-283
Medication Errors in the Outpatient Setting
Medications may be inadequate or overly effective in treating a targeted disease or symptom. They may also cause serious adverse effects or interact with each other and are often prohibitively expensive. To adequately monitor the safety and efficacy of a drug, the prescribing provider requires accurate knowledge about how it is taken. In acute care facilities where medications are handled by trained, credentialed health care workers, acquisition of this information and control of the drug's administration has proven highly challenging. Adverse drug events reported among 6.5% of hospitalized patients were fatal in 1% of the cases and life-threatening in 12%.1 In the outpatient environment, neither the magnitude of this problem nor the severity of the consequences has been well defined. Here, there is no structured mechanism to monitor drug use. Once a prescription is written or conveyed by telephone, a variety of factors may intervene between the intended prescription and administration of the medication, resulting in alterations in the dose, timing, and even the identity of the drug. Such interceding circumstances that remain unrecognized or underestimated are likely to preclude protection of the patient.
- 1 March 2007
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 142 (3) , 278-283
Open AccessMedication Errors in the Outpatient Setting
Medications may be inadequate or overly effective in treating a targeted disease or symptom. They may also cause serious adverse effects or interact with each other and are often prohibitively expensive. To adequately monitor the safety and efficacy of a drug, the prescribing provider requires accurate knowledge about how it is taken. In acute care facilities where medications are handled by trained, credentialed health care workers, acquisition of this information and control of the drug's administration has proven highly challenging. Adverse drug events reported among 6.5% of hospitalized patients were fatal in 1% of the cases and life-threatening in 12%.1 In the outpatient environment, neither the magnitude of this problem nor the severity of the consequences has been well defined. Here, there is no structured mechanism to monitor drug use. Once a prescription is written or conveyed by telephone, a variety of factors may intervene between the intended prescription and administration of the medication, resulting in alterations in the dose, timing, and even the identity of the drug. Such interceding circumstances that remain unrecognized or underestimated are likely to preclude protection of the patient.
- Open Access
- 1 February 2007
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (2) , 480-483
Errors in ABO Labeling of Deceased Donor Kidneys: Case Reports and Approach to Ensuring Patient Safety
- 1 February 2007
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (2) , 480-483
Open AccessErrors in ABO Labeling of Deceased Donor Kidneys: Case Reports and Approach to Ensuring Patient Safety
Payment for living organ donation should be legalised
Governments seem resistant to allowing live donors to benefit from their gift. But a legalised system could solve organ shortages and be both safer and fairer
Payment for living organ donation should be legalised
Governments seem resistant to allowing live donors to benefit from their gift. But a legalised system could solve organ shortages and be both safer and fairer
- 1 January 2006
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 243 (1) , 126-130
Fatal and Nonfatal Hemorrhagic Complications of Living Kidney Donation
After anecdotal reports of severe hemorrhage from failure of surgical clips to sustain closure of renal artery stumps in live donor nephrectomies were received, this study was designed to identify specific surgical techniques that are associated with an increased risk of failure to control bleeding and might represent opportunities to improve patient safety. Preventing complications for living kidney donors must be paramount in addressing end-stage renal failure through living kidney donation. Major hemorrhage from technical failure, albeit an infrequent occurrence, can cause significant, yet preventable, morbidity or death. Open and laparoscopic approaches to living kidney donation use several vascular control methods, some of which may be more prone to failure and life-endangering hemorrhage than others. To define hemorrhagic complications of living kidney donation, a survey was sent to all 893 surgeon-members of the American Society of Transplant Surgeons. Descriptive and bivariate analyses were used to ascertain study participant characteristics, most frequently used vascular control techniques, and incidence of events (death, transfusion, reexploration or conversion to open nephrectomy, or contralateral [remaining kidney] renal failure). Outcomes of hemorrhage and comments by respondents were sought as were data from other sources. In 213 surveys returned (24%), 66 and 39 episodes of arterial and venous hemorrhage were reported, respectively. Among arterial control problems, 2 resulted in donor death and 2 resulted in renal failure; 19 episodes required transfusion. Open conversions in laparoscopic nephrectomy or late reoperations for hemorrhage were reported for 29 cases. Locking and standard clips applied to the renal artery were associated with the greatest risks. Significant hemorrhagic complications occur with living kidney donation in both open and laparoscopic approaches. Loss of arterial control jeopardizes donor life and health, especially when it occurs in the postoperative period. Vascular transfixion provides the best vascular control of major vessels.
- 1 January 2006
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 243 (1) , 126-130
Fatal and Nonfatal Hemorrhagic Complications of Living Kidney Donation
After anecdotal reports of severe hemorrhage from failure of surgical clips to sustain closure of renal artery stumps in live donor nephrectomies were received, this study was designed to identify specific surgical techniques that are associated with an increased risk of failure to control bleeding and might represent opportunities to improve patient safety. Preventing complications for living kidney donors must be paramount in addressing end-stage renal failure through living kidney donation. Major hemorrhage from technical failure, albeit an infrequent occurrence, can cause significant, yet preventable, morbidity or death. Open and laparoscopic approaches to living kidney donation use several vascular control methods, some of which may be more prone to failure and life-endangering hemorrhage than others. To define hemorrhagic complications of living kidney donation, a survey was sent to all 893 surgeon-members of the American Society of Transplant Surgeons. Descriptive and bivariate analyses were used to ascertain study participant characteristics, most frequently used vascular control techniques, and incidence of events (death, transfusion, reexploration or conversion to open nephrectomy, or contralateral [remaining kidney] renal failure). Outcomes of hemorrhage and comments by respondents were sought as were data from other sources. In 213 surveys returned (24%), 66 and 39 episodes of arterial and venous hemorrhage were reported, respectively. Among arterial control problems, 2 resulted in donor death and 2 resulted in renal failure; 19 episodes required transfusion. Open conversions in laparoscopic nephrectomy or late reoperations for hemorrhage were reported for 29 cases. Locking and standard clips applied to the renal artery were associated with the greatest risks. Significant hemorrhagic complications occur with living kidney donation in both open and laparoscopic approaches. Loss of arterial control jeopardizes donor life and health, especially when it occurs in the postoperative period. Vascular transfixion provides the best vascular control of major vessels.
- 1 January 2004
- Published by Springer Nature in International Urology and Nephrology
- Vol. 36 (3) , 451-456
Renal transplant recipients over aged 60 have diminished immune activity and a low risk of rejection
- 1 January 2004
- Published by Springer Nature in International Urology and Nephrology
- Vol. 36 (3) , 451-456
Renal transplant recipients over aged 60 have diminished immune activity and a low risk of rejection
- Open Access
- 1 September 2003
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 138 (9) , 1025
Image of the Month—Diagnosis
A 52-YEAR-OLD man underwent living unrelated donor renal transplantation for treatment of end-stage renal disease caused by congenital obstructive disease. Immu
- 1 September 2003
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 138 (9) , 1025
Open AccessImage of the Month—Diagnosis
A 52-YEAR-OLD man underwent living unrelated donor renal transplantation for treatment of end-stage renal disease caused by congenital obstructive disease. Immu
- 20 June 2003
- Published by Wiley in Hemodialysis International
- Vol. 7 (3) , 250-255
Management of the Surgical Patient with End‐Stage Renal Disease
For health providers guiding the end‐stage renal disease patient's care, conventional surgical and anesthetic principles may demand substantial modifications to optimize both the immediate outcome and long‐term survival. Elective operation is conducted in the setting of optimized acid/base balance, volume status and potassium management with pre‐operative dialysis completed within 24 hours of the procedure (either hemodialysis or peritoneal dialysis). When peripheral intravenous access is inadequate, central venous access is obtained preferentially through the internal jugular veins because of the catastrophic consequences of catheter‐induced subclavian stenosis. Infectious prophylaxis incorporates antibiotic selection considering the lack of native renal drug clearance, the potential for drug loss across dialysis membranes and potential interactions with immunosuppressive medications. Judicious intraoperative blood and fluid replacement should not be so restricted as to permit inadequate end organ perfusion, even if post‐operative dialysis is necessitated. Hemostasis may be facilitated by the use of desmopressin to correct uremic platelet dysfunction. Wound closure techniques should accommodate the delayed healing associated with kidney failure and/or iatrogenic immunosuppression.
- 20 June 2003
- Published by Wiley in Hemodialysis International
- Vol. 7 (3) , 250-255
Management of the Surgical Patient with End‐Stage Renal Disease
For health providers guiding the end‐stage renal disease patient's care, conventional surgical and anesthetic principles may demand substantial modifications to optimize both the immediate outcome and long‐term survival. Elective operation is conducted in the setting of optimized acid/base balance, volume status and potassium management with pre‐operative dialysis completed within 24 hours of the procedure (either hemodialysis or peritoneal dialysis). When peripheral intravenous access is inadequate, central venous access is obtained preferentially through the internal jugular veins because of the catastrophic consequences of catheter‐induced subclavian stenosis. Infectious prophylaxis incorporates antibiotic selection considering the lack of native renal drug clearance, the potential for drug loss across dialysis membranes and potential interactions with immunosuppressive medications. Judicious intraoperative blood and fluid replacement should not be so restricted as to permit inadequate end organ perfusion, even if post‐operative dialysis is necessitated. Hemostasis may be facilitated by the use of desmopressin to correct uremic platelet dysfunction. Wound closure techniques should accommodate the delayed healing associated with kidney failure and/or iatrogenic immunosuppression.
- 1 January 2001
- Published by Elsevier in Advances in Renal Replacement Therapy
- Vol. 8 (1) , 70-82
Appropriateness and Timing of Kidney and/or Pancreas Transplants in Type 1 and Type 2 Diabetes
- 1 January 2001
- Published by Elsevier in Advances in Renal Replacement Therapy
- Vol. 8 (1) , 70-82
Appropriateness and Timing of Kidney and/or Pancreas Transplants in Type 1 and Type 2 Diabetes
- 1 December 1995
- Vol. 27 (6) , 3037
Serum sialic acid, a risk factor for cardiovascular disease, improves following pancreas transplantation.
- 1 December 1995
- Vol. 27 (6) , 3037
Serum sialic acid, a risk factor for cardiovascular disease, improves following pancreas transplantation.